Experts' plan to cut heart deaths

All well and good in this article but look at the following from NHSBLOGDOC.

Also have a look at The Scotsman and some of the comments.

Is this driven by a want for profit or is it a good thing. As he says Statins are big business. Very big business.

I saw five patients today who are on statins, and they all had questions about safety, and memory loss and the "new statin" that has turned out to be dangerous. I worry about this more and more. I ask myself, how much do I REALLY know about the efficacy and safety of these drugs? I am merely the victim of the latest reseach paper.

Pfizer’s next big drug for heart disease (torcetrapib which was slated to replace Lipitor) has bombed in trials, causing sufficient deaths that the trials have been ended early and development has been stopped. This is obviously dreadful news for Pfizer, and I assume that the stock will be well done on Monday. But that’s how the pharma business is supposed to work—big bets on new blockbusters may not pan out, but others will do so. (Matthew Holt)

Statins are big business. Very big business.

An academic colleague in the Southern Hemisphere sends me regular updates on the dangers of statins. He draws my attention to this:

Frank Cooper - author of "Cholesterol and the French Paradox".

France is a nation of 62,000,000 people who have been eating foods high in saturated fats and cholesterol for a long time, and yet they enjoy very low levels of heart disease. Frank will explain how the French eat 3 times as much fat and cholesterol as Americans yet have 1/3 the deaths from heart attacks. (Source)

Popular medicine, maybe. But can someone explain it to me? Then I can explain it to my patients.

BBC NEWS | Scotland | Experts' plan to cut heart deaths